Chen-Chih Chung1, Daniela Pimentel1, Azizah J Jor'dan1, Ying Hao1, William Milberg1, Vera Novak2. 1. From the Departments of Neurology (C.-C.C., D.P., V.N.) and Gerontology (D.P., A.J.J., Y.H., V.N.), Beth Israel Deaconess Medical Center, Boston, MA; Department of Neurology (C.-C.C.), Shuang Ho Hospital, Taipei Medical University, Taiwan; Institute for Aging Research, Hebrew SeniorLife (A.J.J.), and New England Geriatric, Research, Education and Clinical Center-Boston Division, VA Boston Healthcare, and Department of Psychiatry (W.M.), Harvard Medical School, Boston, MA; and School of Acupuncture-Moxibustion and Tuina (Y.H.), Beijing University of Chinese Medicine, China. 2. From the Departments of Neurology (C.-C.C., D.P., V.N.) and Gerontology (D.P., A.J.J., Y.H., V.N.), Beth Israel Deaconess Medical Center, Boston, MA; Department of Neurology (C.-C.C.), Shuang Ho Hospital, Taipei Medical University, Taiwan; Institute for Aging Research, Hebrew SeniorLife (A.J.J.), and New England Geriatric, Research, Education and Clinical Center-Boston Division, VA Boston Healthcare, and Department of Psychiatry (W.M.), Harvard Medical School, Boston, MA; and School of Acupuncture-Moxibustion and Tuina (Y.H.), Beijing University of Chinese Medicine, China. vnovak@bidmc.harvard.edu.
Abstract
OBJECTIVE: The aim of this prospective study was to investigate the relationships between inflammation, cerebral vasoregulation, and cognitive decline in type 2 diabetes mellitus (T2DM) over a 2-year span. METHODS: Sixty-five participants (aged 66 ± 9.2 years, 35 with T2DM, 33 women) were enrolled for this 2-year prospective study. Continuous arterial spin labeling at 3-tesla MRI was used to measure global and regional cerebral perfusion and vasoreactivity. Neuropsychological measures were evaluated at the beginning and completion of the study. The associations between serum inflammatory markers, regional cerebral vasoreactivity, and cognitive functions were examined using least squares models. RESULTS: After 2 years of follow-up, participants with T2DM had diminished global and regional cerebral vasoreactivity and a decline in multiple cognitive tasks compared with baseline (p < 0.0001-0.012). In the T2DM group, lower cerebral vasoreactivity was associated with a greater decrease in daily living activities score (r(2) adj = 0.35, p = 0.04), and lower global vasodilation was associated with a greater decline in executive function (r(2) adj = 0.6, p = 0.047). Higher serum soluble intercellular and vascular adhesion molecules, higher cortisol, and higher C-reactive protein levels at baseline were associated with greater decreases in cerebral vasoreactivity and vasodilation only in the T2DM group (r(2) adj = 0.16-0.53, p = 0.007-0.048), independent of diabetes control and 24-hour blood pressure. Higher glycated hemoglobin A1c levels were associated with a greater increase in vasoconstriction in the T2DM group. CONCLUSIONS: Inflammation may further impair cerebral vasoregulation, which consequently accelerates decline in executive function and daily activities performance in older people with T2DM.
OBJECTIVE: The aim of this prospective study was to investigate the relationships between inflammation, cerebral vasoregulation, and cognitive decline in type 2 diabetes mellitus (T2DM) over a 2-year span. METHODS: Sixty-five participants (aged 66 ± 9.2 years, 35 with T2DM, 33 women) were enrolled for this 2-year prospective study. Continuous arterial spin labeling at 3-tesla MRI was used to measure global and regional cerebral perfusion and vasoreactivity. Neuropsychological measures were evaluated at the beginning and completion of the study. The associations between serum inflammatory markers, regional cerebral vasoreactivity, and cognitive functions were examined using least squares models. RESULTS: After 2 years of follow-up, participants with T2DM had diminished global and regional cerebral vasoreactivity and a decline in multiple cognitive tasks compared with baseline (p < 0.0001-0.012). In the T2DM group, lower cerebral vasoreactivity was associated with a greater decrease in daily living activities score (r(2) adj = 0.35, p = 0.04), and lower global vasodilation was associated with a greater decline in executive function (r(2) adj = 0.6, p = 0.047). Higher serum soluble intercellular and vascular adhesion molecules, higher cortisol, and higher C-reactive protein levels at baseline were associated with greater decreases in cerebral vasoreactivity and vasodilation only in the T2DM group (r(2) adj = 0.16-0.53, p = 0.007-0.048), independent of diabetes control and 24-hour blood pressure. Higher glycated hemoglobin A1c levels were associated with a greater increase in vasoconstriction in the T2DM group. CONCLUSIONS: Inflammation may further impair cerebral vasoregulation, which consequently accelerates decline in executive function and daily activities performance in older people with T2DM.
Authors: J M Starr; J Wardlaw; K Ferguson; A MacLullich; I J Deary; I Marshall Journal: J Neurol Neurosurg Psychiatry Date: 2003-01 Impact factor: 10.154
Authors: Robert K Heaton; Natacha Akshoomoff; David Tulsky; Dan Mungas; Sandra Weintraub; Sureyya Dikmen; Jennifer Beaumont; Kaitlin B Casaletto; Kevin Conway; Jerry Slotkin; Richard Gershon Journal: J Int Neuropsychol Soc Date: 2014-06-24 Impact factor: 2.892
Authors: Connie W Tsao; Sudha Seshadri; Alexa S Beiser; Andrew J Westwood; Charles Decarli; Rhoda Au; Jayandra J Himali; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Martin G Larson; Emelia J Benjamin; Philip A Wolf; Ramachandran S Vasan; Gary F Mitchell Journal: Neurology Date: 2013-08-09 Impact factor: 9.910
Authors: Vera Novak; Peng Zhao; Brad Manor; Ervin Sejdic; David Alsop; Amir Abduljalil; Paula K Roberson; Medha Munshi; Peter Novak Journal: Diabetes Care Date: 2011-09-16 Impact factor: 19.112
Authors: Naomi Kakoschke; Ian T Zajac; Jeannie Tay; Natalie D Luscombe-Marsh; Campbell H Thompson; Manny Noakes; Jonathan D Buckley; Gary Wittert; Grant D Brinkworth Journal: Eur J Nutr Date: 2021-05-20 Impact factor: 5.614